BENDAMUSTINE IS NOT ASSOCIATED WITH AN INCREASE IN INFECTIONS – SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

EHA Library, Anat Gafter-Gvili, 53885

EXPRESSION OF CD200 AND CD148 IN LEUKEMIC B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Lei Fan, 53886

ABEXINOSTAT (S78454) A HISTONE DEACETYLASE INHIBITOR, IN PATIENTS WITH REFRACTORY OR RELAPSED HODGKIN'S LYMPHOMA, NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA: PRELIMINARY PHASE II RESULTS.

EHA Library, broussais-guillaumot florence, 53887

HIGH-DOSE CLARITHROMYCIN IS A FEASIBLE AND ACTIVE MONOTHERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY EXTRANODAL MARGINAL ZONE LYMPHOMA [EMZL]: RESULTS FROM THE 'HD-K' PHASE II TRIAL

EHA Library, Andres Jose Maria Ferreri, 53888

EPIDEMIOLOGY OF NON-HODGKIN LYMPHOMA IN THE US: DISTRIBUTION BY SUBTYPES, DEMOGRAPHICS, AND TRENDS FROM 1998-2011

EHA Library, Ronald Go, 53889

CLINICAL COMPARABILITY OF BCD-020 TO INNOVATOR RITUXIMAB IN PATIENTS WITH INDOLENT NON-HODGKIN'S LYMPHOMA

EHA Library, Ekaterina Chernyaeva, 53894

OCCURRENCE OF CHRONIC THERAPY-RELATED HYPOGAMMAGLOBULINAEMIA IN INDOLENT NON HODGKIN LYMPHOMA: SINGLE CENTRE EXPERIENCE.

EHA Library, Alessandro Pulsoni, 53895

PERIPHERAL BLOOD LYMPHOCYTE/MONOCYTE RATIO (LMR) >2 IS ASSOCIATED WITH BETTER OUTCOME IN FOLLICULAR LYMPHOMA (FL): A SINGLE CENTRE EXPERIENCE

EHA Library, ANGELO BELOTTI, 53896

THE SECOND PRIMARY CANCER RISK AFTER NON HODGKIN LYMPHOMA IS NOT INFLUENCED BY THE SUBTYPE: DATA FROM THE FRENCH CANCER REGISTRIES NETWORK (FRANCIM).

EHA Library, Cédric Rossi, 53899

HEAVY/LIGHT CHAIN CHARACTERISTICS OF PATIENTS WITH INDOLENT AND AGGRESSIVE LYMPHOMAS

EHA Library, Oscar Berlanga, 53900

R-CHOP THERAPY ALONE FOR LIMITED-STAGE FOLLICULAR LYMPHOMA: A RETROSPECTIVE STUDY

EHA Library, Naoto Tomita, 53901

PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN RELAPSED-REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Matthew Wasserman, 53902

Frequency of surveillance computed tomography in non-Hodgkin lymphoma and risk of secondary primary malignancies

EHA Library, Sheng-Hsuan Chien, 53903

MYD88 (L265P) MUTATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Conchi Fernández Rodríguez, 53905

THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION

EHA Library, Ferras Alwan, 53906

APOPTOTIC POLYMORPHISMS ARE INVOLVED IN AGGRESSIVENESS AND PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Angelo Brito, 53909

BRENTUXIMAB VEDOTIN IN REFRACTORY OR RELAPSED PERIPHERAL T-CELL LYMPHOMA: THE FRENCH NAME PATIENT PROGRAM EXPERIENCE IN 65 PATIENTS

EHA Library, Lamarque Mathilde, 53911

THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) ACTIVITY IN DOUBLE HIT DIFFUSE LARGE B CELL LYMPHOMAS (DLBCL) IN PRECLINICAL MODELS & CLINICAL ACTIVITY IN PATIENTS WITH DLBCL

EHA Library, CHRISTINE CHEN, 53912

CLINICAL IMPACT OF INCLUSION AND TIMING OF RADIOTHERAPY IN THE TREATMENT OF LIMITED-STAGE NK/T-CELL LYMPHOMA

EHA Library, Bohee Lee, 53914

EFFICALY OF M-NHL-BFM-90 TREATMENT PROTOCOL FOR PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Anna Misyurina, 53915

BISPECIFIC T-CELL ENGAGER (BiTE®) ANTIBODY BLINATUMOMAB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): AN OPEN-LABEL PHASE 2 STUDY

EHA Library, Andreas Viardot, 53916

NON PEGILATED LIPOSOMAL DOXORUBICIN IS SAFE AND EFFECTIVE AS PART OF R-COMP IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND MODERATE/SEVERE HEART DISEASE. RESULTS OF HEART01 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Michele Spina, 53917

HIGH DOSES OF ANTIMETABOLITES FOLLOWED BY HIGH-DOSE SEQUENTIAL CHEMOIMMUNOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN SYSTEMIC B-CELL LYMPHOMAS WITH CNS INVOLVEMENT: A MULTICENTER PHASE II TRIAL

EHA Library, Andres Jose Maria Ferreri, 53918

R-ESHAP-LENALIDOMIDE AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA CANDIDATES TO STEM-CELL TRANSPLANTATION: UPDATED RESULTS OF A PHASE IB GELTAMO STUDY

EHA Library, Alejandro Martín, 53919

NCCN-INTERNATIONAL PROGNOSTIC INDEX (NCCN-IPI) IS A POTENTIAL PROGNOSTIC MODEL IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA

EHA Library, Pengpeng Xu, 53920

RITUXIMAB-CHOP PLUS INTRATHECAL METHOTREXATE AND CONTRALATERAL TESTIS IRRADIATION IN UNTREATED PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA: LONG-TERM RESULTS OF THE IELSG-10 TRIAL

EHA Library, Annalisa Chiappella, 53921

THE NOVEL ROLE OF BONE MARROW INVOLVEMENT DETECTED BY BOTH STAGING AND INTERIM FDG PET-CT IN DIFFUSE LARGE B-CELL LYMPHOMAS

EHA Library, Wei Xu, 53922

MIR-155 IS ASSOCIATED WITH THE LEUKEMOGENIC POTENTIAL OF CLASS IV G-CSFR IN CD34+ PROGENITOR CELLS

EHA Library, Constanca Ferreira de Figueiredo, 53923

THE ROLE OF EPITHELIAL TO MESENCHYMAL TRANSITION IN THE REMODELING OF LUNG INJURY INDUCED BY ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Qifa Liu, 53924

RECIPIENT BATF3 DEPENDENT DENDRITIC CELLS SUPPRESS ACUTE GRAFT-VERSUS-HOST DISEASE AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION

EHA Library, Markus Radsak, 53928

DISRUPTED TOLL-LIKE RECEPTOR SIGNALING OF INTESTINAL EPITHELIUM IN INTESTINAL GRAFT-VERSUS-HOST DISEASE

EHA Library, Qifa Liu, 53929

RECONSTITUTION OF GPI-ANCHOR-NEGATIVE NK CELL POPULATIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING ALEMTUZUMAB-BASED CONDITIONING

EHA Library, Aline Naomi Lay, 53931

ACTIVATED MONOCYTE-PHAGOCYTES PROBABLY INITIATE THE ONSET OF PRE-ENGRAFTMENT SYNDROME (PES) FOLLOWING UMBILICAL CORD BLOOD TRANSPLANTATION

EHA Library, Jian Wang, 53933

INFLUENCE OF HLA-G POLYMORPHISM ON VIRAL REACTIVATION AND OVERALL SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Elisabetta Metafuni, 53934

MYELOID DERIVED SUPPRESSOR CELLS ARE MOBILIZED BY G-CSF IN MICE AND MEN

EHA Library, Katrin Wetzko, 53935

GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION AFFECTS THE EXPRESSION OF TH1/TH2 CHEMOKINES AND THEIR RECEPTORS

EHA Library, Qifa Liu, 53936

GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION AFFECTS THE EXPRESSION OF REGULATORY GAMMA DELTA T CELLS

EHA Library, Qifa Liu, 53937

EFFECT OF UPREGULATED TLR2 EXPRESSION FROM G-CSF-MOBILIZED DONOR GRAFT ON ACUTE GRAFT-VERSUS-HOST DISEASE IN MICE

EHA Library, Young-Don Joo, 53940

ALDEHYDE DEHYDROGENASE-BRIGHT CELLS CORRELATED WITH THE COLONY FORMING UNIT-GRANULOCYTE/MACROPHAGE ASSAY OF THAWED CORD BLOOD UNITS

EHA Library, Hye Ryun Lee, 53941

A MACHINE LEARNING BASED MODEL FOR PREDICTION OF NRM 100 DAYS POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT). A EUROPEAN REGISTRY DATA MINING STUDY.

EHA Library, Roni Shouval, 53942

CONTRASTING EFFECT OF MISSING SELF MODEL AND ACTIVATING DONOR KIR GENES WITH RELEVANT HLA LIGAND IN RECIPIENTS ON PREVENTING RELAPSE AFTER T-CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION IN CML

EHA Library, Xiangyu Zhao, 53943

IMPACT OF SMOKING ON THE NON-RELAPSE MORTALITY, THE OVERALL SURVIVAL, AND THE INCIDENCE OF SECOND CANCERS AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Francesco Spina, 53944

A POTENTIAL BENEFIT OF INHIBITORY KIR-MISMATCHED UNMANIPULATED HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOLLOWING TBI-BASED CONDITIONING IN ADULT PATIENTS WITH AML

EHA Library, Seung-Ah Yahng, 53947

HIGH BURDEN OF CD34+/CD38-CELLS PREDICTS WORSE OUTCOME IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (HCT) WITH REDUCED INTENSITY CONDITIONING (RIC)

EHA Library, Madlen Jentzsch, 53948

PROGNOSTIC SIGNIFICANCE OF IDH MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS UNDERGOING HEMATOPIETIC STEMCELL TRANSPLANTATION (HCT) AFTER REDUCED INTENSITY CONDITIONING (RIC)

EHA Library, Marius Bill, 53949

DECREASE OF INVASIVE FUNGAL DISEASE IN OUR CENTER WITH THE USE OF VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Carolina Chic Acevedo, 53952

LONG-TERM SURVIVAL IN PATIENTS RECEIVING RHEPO FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Aurélie Jaspers, 53953

PLASMA PROHNPS ARE SPECIFIC EARLY MARKERS OF NEUTROPHIL ENGRAFTMENT IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, AUTOLOGOUS OR ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Andreas Glenthøj, 53955

HIGH-DOSE PREPARATION WITH THIOTEPA/ETOPOSIDE/ARA-C/MELPHALAN (TEAM) VS BEAM FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN LYMPHOMA: A RETROSPECTIVE STUDY FROM THE EBMT

EHA Library, Peter Dreger, 53957

CO-TRANSPLANTATION OF HAPLOIDENTICAL TRANSPLANTATION AND UMBILICAL CORD BLOOD UNIT PROVIDE SIGNIFICANT SURVIVAL BENEFIT FOR PATIENTS WITH LEUKEMIA

EHA Library, Depei Wu, 53958

THE IMPACT OF PRETRANSPLANT IRON CHELATING THERAPY WITH DEFERASIROX ON THE OUTCOME IN PATIENTS WITH SEVERE APASTIC ANEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Sung-Eun Lee, 53960

IMPACT OF MONOSOMAL KARYOTYPE ON THE OUTCOMES OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION FOR OLDER PATIENTS (>60 YEARS OF AGE) WITH AML/MDS.

EHA Library, Jose Leis, 53961

LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE

EHA Library, Oxana Bereshchenko, 53964

A ROLE OF C/EBP-ALPHA IN DEVELOPMENT OF PLASMACYTOID DENDRITIC CELLS IN THE THYMUS

EHA Library, Albert Wölfler, 53968

HISTONE DEACETYLACE INHIBITOR VORINOSTAT REDUCES KIT EXPRESSION IN SYSTEMIC MASTOCYTOSIS

EHA Library, Hani Abdulkadir Ali, 53970

ASSOCIATION OF AN IMPAIRED BONE MARROW VASCULAR MICROENVIRONMENT WITH PRIMARY FAILURE OF PLATELET ENGRAFTMENT AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yuan Kong, 53971

REGULATION OF B LYMPHOPOIESIS BY SIGNAL-TRANSDUCING ADAPTOR PROTEIN-2, STAP-2

EHA Library, Michiko Ichii, 53972

IMPACT OF COLD SHOCK PROTEIN YBX1 ON HEMATOPOIETIC STEM CELL DEVELOPMENT AND FUNCTION

EHA Library, Florian Heidel, 53973

IMMUNOMODULATION EFFECTS OF MESENCHYMAL STEM CELLS IN THE TREATMENT OF REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Qifa Liu, 53975

MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES

EHA Library, Emiliano Fabiani, 53977

ADDITION OF PLERIXAFOR TO G-CSF IMPROVES THE GRAFT CONTENT IN SIDE POPULATION (SP) WITH IMMATURE PHENOTYPE IN PATIENTS THAT FAILED TO RESPOND WELL TO G-CSF ALONE.

EHA Library, Bijou Fontanet, 53978

THE IRON CHELATOR DEFERASIROX AFFECTS REDOX SIGNALING IN HEALTHY HEMATOPOIETIC STEM CELLS

EHA Library, Tiziana Tataranni, 53979

ADMISSION OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES TO INTENSIVE CARE UNITS

EHA Library, Margarida Badior, 54030

PROSPECTIVE OBSERVATIONAL STUDY ON CHEMOTHERAPY- INDUCED NAUSEA AND VOMITING (CINV) FOR HEMATOLOGIC MALIGNANCY PATIENTS AND PRIMARY CARE MEDICAL STAFF'S PERCEPTION BY THE CINV STUDY GROUP OF JAPAN

EHA Library, Isao Yoshida, 54031

PROPHYLAXIS WITH FEBUXOSTAT IN COMPARISON TO ALLOPURINOL REDUCES EXPOSURE TO URIC ACID IN PATIENTS AT INTERMEDIATE TO HIGH RISK OF TUMOR LYSIS SYNDROME: RESULTS OF THE FLORENCE STUDY

EHA Library, Simone Baldini, 54032

BUFFY COAT POOLED PLATELETS CRYOPRESERVED IN DIMETHYL-SULPHOXIDE WITH A NEW SYSTEM PRESERVE THEIR IN VITRO FUNCTION UP TO 9 MONTHS

EHA Library, Giorgia Saccullo, 54033

HEMOSTATIC FUNCTION AND BIOMARKERS OF ENDOTHELIAL DAMAGE BEFORE AND AFTER PLATELET TRANSFUSION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anne Mett Larsen, 54034

ASSESSING RISK OF BLEEDING IN THROMBOCYTOPENIC PATIENTS REQUIRING PLATELET TRANSFUSION PRIOR TO INVASIVE PROCEDURES

EHA Library, Mohamed Al Zaabi, 54036

RED CELL BLOOD GROUP GENOTYPING IN A COHORT OF BLOOD DONORS: FOCUS ON THE DUFFY ANTIGEN SYSTEM

EHA Library, Anna Colpo, 54037

A NEW BLOOD PRODUCT SUPPORT PROTOCOL HAS SIGNIFICANTLY REDUCED MASSIVE BLOOD LOSS IN PATIENTS UNDERGOING SURGERY FOR PSEUDOMYXOMA PERITONEI.

EHA Library, Nigel Sargant, 54038

RED BLOOD CELL ALLOIMMUNIZATION IN 18 – 50 YEAR OLD TRANSFUSED WOMEN A 3 YEAR STUDY

EHA Library, Pierre Moncharmont, 54039

RED BLOOD CELLS ALLOIMMUNIZATION IN POLYTRANSFUSED PATIENTS.

EHA Library, Irene Lucea, 54040

IDENTIFICATION OF ABCB6 GENETIC VARIANTS WITH LOW OR ABSENT PROTEIN EXPRESSION AS THE GENETIC BASIS OF HIGH FREQUENCY BLOOD GROUP ANTIGEN LANGEREIS

EHA Library, Magdalena Koszarska, 54041

ANALYSIS OF ADVERSE REACTIONS IN VOLUNTARY WHOLE BLOOD DONORS: EXPERIENCE FROM A GREEK BLOOD CENTRE

EHA Library, Iakovos Proysanidis, 54042

LEUKOREDUCTION FILTER OBSTRUCTION - THE OPPORTUNITY TO DETECT BLOOD DONORS WITH SICKLE CELL TRAIT

EHA Library, Iakovos Proysanidis, 54043

EVALUATION OF BILIARY INJURY IN NEWBORNS WITH ABO INCOMPATIBILITY

EHA Library, Rania El-Farrash, 54045

FEASIBILITY OF ROMIPLOSTIM DISCONTINUATION IN ADULT TPO-MIMETIC RESPONSIVE PATIENT WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): AN OBSERVATIONAL RETROSPECTIVE REPORT IN REAL LIFE CLINICAL PRACTICE

EHA Library, Monica Carpenedo, 54048

SHORT TERM RE-EXPOSURE TO ROMIPLOSTIM IN PREVIOUSLY TPO-MIMETIC RESPONSIVE ITP PATIENTS ALLOWS RECOVERY OF PLATELET COUNT AND LONG TERM SUSTAINED REMISSION: AN OBSERVATIONAL RETROSPECTIVE CASE-SERIES

EHA Library, Monica Carpenedo, 54051

THROMBOPOIETIN RECEPTOR AGONISTS IN PRIMARY IMMUNE THROMBOCYTOPENIA: EVALUATION OF EFFICACY (RESPONSE AND SUSTAINED RESPONSE OFF-TREATMENT) AND SAFETY IN A SINGLE CENTER POPULATION.

EHA Library, Cristina Santoro, 54052

PREDICTIVE FACTORS ASSOCIATED WITH LONG-TERM EFFECTS OF SPLENECTOMY FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA

EHA Library, Mirjana Mitrovic, 54053

THROMBOPOIETIN RECEPTOR AGONISTS AFFECTS THE LEVELS OF HEPATOCYTE GROWTH FACTOR AND TRANSFORMING GROWTH FACTORS IN IMMUNE THROMBOCYTOPENIA

EHA Library, Waleed Ghanima, 54054

PREOPERATIVE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ITP PATIENTS PRIOR TO SPLENECTOMY OR CARDIOVASCULAR SURGERY.

EHA Library, Valerio De Stefano, 54055

A SINGLE CENTRE RETROSPECTIVE ANALYSIS OF 57 A SINGLE CENTRE RETROSPECTIVE ANALYSIS OF 57 CONSECUTIVE LAPAROSCOPIC SPLENECTOMIES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Edgardo Barranco, 54056

THE TREATMENT WITH ELTROMBOPAG OF THE REFRACTORY ITP

EHA Library, Mihnea-Alexandru Găman, 54057

THROMBOPOIETIC AGENTS INCREASE PLATELET COUNTS MORE EFFECTIVELY IN ITP PATIENTS WITH HIGHER PLATELET PRODUCTION PRIOR TO TREATMENT

EHA Library, James Bussel, 54058

ELTROMBOPAG GIVEN 2 TIMES A WEEK AS MAINTENANCE THERAPY IN RESPONDING PATIENTS AFTER AN INDUCTION STANDARD TREATMENT OF 50 MG ORALLY ONCE DAILY IS EQUALLY EFFECTIVE AND SAFE IN ITP PATIENTS.

EHA Library, Francesco Iuliano, 54059

ROMIPLOSTIM: EFFICACY AND SAFETY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP). SINGLE CENTRE EXPERIENCE

EHA Library, Irina Zotova, 54060

CORRELATION BETWEEN OXIDATIVE STRESS AND BIOMARKERS OF JOINT DAMAGE IN PATIENTS WITH SEVERE HAEMOPHILIA TREATED BY DIFFERENT PROPHYLAXIS REGIMENS

EHA Library, Marijana Virijevic, 54061

BONE MINERAL DENSITY IN MEN AND CHILDREN WITH HAEMOPHILIA A AND B: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Panagiotis Anagnostis, 54062

CAN SECONDARY PROPHYLAXIS IN HAEMOPHILIA BE A CAUSE OF ISCHEMIA?

EHA Library, Mehmet Sonmez, 54063

APPLICATION OF THE US NATIONAL INSTITUTE OF HEALTH (NIH) 2008 GUIDELINES FOR VON WILLEBRAND DISEASE IN A NATIONAL PAEDIATRIC COMPREHENSIVE CARE CENTRE.

EHA Library, Irene Regan, 54064

MONITORING OF SUBSTITUTION THERAPY WITH RECOMBINANT FACTOR XIII OF A PATIENT WITH SEVERE FACTOR XIII A SUBUNIT DEFICIENCY

EHA Library, Laszlo Muszbek, 54066

OPTIMAL MANAGEMENT OF A RARE COAGULATION DISORDER: FACTOR V DEFICIENCY

EHA Library, Mohamed Elshinawy, 54067

THE CLINICOLABORATORY CHARACTERISTICS AND TREATMENT OUTCOMES OF 10 KOREAN PATIENTS WITH FACTOR V DEFICIENCY

EHA Library, Young Hoon Park, 54068

DETECTION OF ANTI-THROMBOPOIETIN AUTOANTIBODY AMONG IMMUNE THROMBOCYTOPENIC PATIENTS

EHA Library, Koji Miyazaki, 54069

HOMOZYGOUS PROTEIN C DEFICIENCY: A DESCRIPTION OF TWO NEW CASES AND LONG-TERM SURVIVAL OF A THIRD CASE SUCCESSFULLY TREATED WITH ORAL ANTICOAGULANT THERAPY, A REPORT FROM SAUDI ARABIA

EHA Library, Yasser Elborai, 54070

AN AUDIT TO DETERMINE THE SAFETY OF THE NOVEL ORAL ANTICOAGULANTS, DABIGATRAN AND RIVAROXABAN, FOR PATIENTS INITIATED ON ANTICOAGULANT THERAPY

EHA Library, Hariney Kurunadalingam, 54071

COMPREHENSIVE SYMPTOM PROFILE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: PRACTICABILITY AND SENSITIVITY OF THE NEW SYMPTOM ASSESSMENT TOOL CSP LEUK-CML

EHA Library, Tatyana Ionova, 54072

PROGNOSTIC VALUE OF NEUROPSYCHOLOGICAL AND BIOLOGICAL FACTORS IN OLDER PATIENTS WITH HEMATOLOGICAL MALIGNANCIES ADMITTED TO RECEIVE CHEMOTHERAPY

EHA Library, Stephanie Dubruille, 54073